ADRB2 and hematologic disorder: These findings have significant translational potential for using exercise as a nontoxic and economical therapeutic strategy—or in repurposing existing drugs that target β2-AR signaling—to augment the manufacture of therapeutic cell products for the treatment of refractory and relapsed hematologic malignancies.